Advice and outreach

For Bioithas, disseminating knowledge to specialists and users is a fundamental objective that will allow us to continue to make progress thanks to our knowledge of the concerns among the populace.

Our experience in research in the field of the human microbiota and probiotics, both in the public and private sectors, has allowed us—especially the founder and Scientific Director of Bioithas, Dr. Vicente Navarro—to act as scientific advisors to several pharmaceutical and food enterprises and companies for the development of their new products and R&D projects.

All this has given us a great deal of experience in the field of scientific outreach in our field of research, giving talks and presentations at a multitude of national and international congresses and conferences, research centres, hospitals and private clinics.

Academic awards for science outreach

Our effort is rewarded

Among our awards that recognize our value, we highlight:

Winners of the Community of Valencia Scale Up Programme of the European Centre for Innovative Enterprises (CEEI) and the Valencian Institute for Business Competitiveness (IVACE).

November 2021

Award of the Network of the Five Science Parks of the Community of Valencia. Best start-up in the Community of Valencia.

December 2019

Award for the four best start-ups in the province of Alicante.

November 2019

Association of Biotechnology Companies of the Community of Valencia (BIOVAL) award.

October 2019

National award for the best clinical research work in all editions of the annual National Congress of the Spanish Society of Probiotics and Prebiotics.

from 2017 to 2021

Other academic awards for scientific dissemination can be seen here.

Our accreditations

Innovative SME Seal
Innovative Technology-Based Enterprise (EIBT) Seal

If you want more information

Fill in your details and we will contact you.

    All personal data that you submit us via this form will be processed by Data Controller BIOITHAS, S.L. and saved into CONTACTS processing activitie, with the purpose of answering your inquiry, via email or phone, and for a later follow up.

    Processing shall be lawful because you give us your consent for these specific purposes. Your personal data will not be disclosed to third parties unless forced by law. You have right to access to, rectify, or delete your personal data, and other rights as explained in our Privacy Policy: https://www.adelopd.com/privacidad/bioithas-sl

    You may be interested in

    Scientist Articles

    Below, we detail the scientific articles published and led by our scientific director, Vicente Navarro López, in several of the most important indexed journals in the world:

    Título Publicación

    Descriptive Study of Gut Microbiota in Infected and Colonized Subjects by Clostridiodes difficile

    Microorganisms, 2021; 9(8):1727. doi: 10.3390/microorganisms9081727.

    Probiotics in the Therapeutic Arsenal of Dermatologists

    Microorganisms, 2021; 9(7):1513. doi: 10.3390/microorganisms9071513.

    Study of the Vaginal Microbiota in Healthy Women of Reproductive Age

    Microorganisms, 2021; 9(5):1069. doi: 10.3390/microorganisms9051069.

    Changes in Gut Microbiota Correlates with Response to Treatment with Probiotics in Patients with Atopic Dermatitis. A Post Hoc Analysis of a Clinical Trial.

    Microorganisms, 2021; 9(4): 854, doi: 10.3390/microorganisms9040854.

    Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: a Randomized Clinical Trial.

    Acta Dermato-Venereologica, 2019; 99(12): 1078-1084, doi:10.2340/00015555-3305.

    Gut microbial composition in patients with psoriasis.

    Scientific Reports, 2018; 8(1): 3812, doi: 10.1038/s41598-018-22125-y.

    OTHER

    Effect of Oral Administration of a Mixture of Probiotic Strains on SCORAD Index and Use of Topical Steroids in Young Patients With Moderate Atopic Dermatitis: A Randomized Clinical Trial. JAMA Dermatology, 2018; 154(1): 37–43, doi: 10.1001/jamadermatol.2017.3647.

    Identification of Bacterial DNA in the Peripheral Blood of Patients With Active Psoriasis.  JAMA Dermatology, 2015; 151(6): 670-1, doi: 10.1001/jamadermatol.2014.5585.   

    Pedro Sanchez Pellicer; Ruth Gonzalez Tamayo; Vicente Navarro Lopez. Reducing test request for anti-thyroglobulin and anti-thyroid peroxidase antibodies: trends before and after interventions based on rejection rules and profile management. Biochemia Medica. 28 – 3, pp. https://doi.org/10.11613/BM.2018.030709. Croatian Society of Medical Biochemistry and Laboratory Medicine, 01/10/2018

    We are baked by scientific experience, and you can count on us.

    Publications at conferences:

    La microbiota intestinal como nuevo factor pronóstico de la esclerosis múltiple remitente recurrente. [Gut microbiota as a new prognostic factor in relapsing remitting multiple sclerosis]. “72nd Annual Meeting of the Spanish Society of Neurology”, 23/11/2020 –  03/12/2020.

    La microbiota salivar como propuesta de biomarcador diagnóstico en cáncer de cabeza y cuello. [Salivary microbiota as a proposed diagnostic biomarker in head and neck cancer]. “11th Workshop of the Spanish Society of Microbiota, Probiotics and Prebiotics (SEMiPyP)”. Granada, 7/02/2020 – 9/02/2020.

    Una nueva diana para el tratamiento del acné vulgar.[A new target for the treatment of acne vulgaris]. Pilot research study. Spanish Academy of Dermatology and Venereology (AEDV) 2019, 47th National Congress of Dermatology and Venereology. Barcelona, 05/06/2019 – 08/06/2019.

    Ensayo clínico aleatorizado doble ciego controlado con placebo para evaluar la seguridad y el efecto de una mezcla probiótica sobre el índice PASI en pacientes con psoriasis moderada. [Randomised, double-blind, placebo-controlled clinical trial to evaluate the safety and effect of a probiotic mixture on the PASI in patients with moderate psoriasis]. AEDV 2018, 46th National Congress of Dermatology and Venereology. Palma de Mallorca, 09/05/2018 – 12/05/2018.

    Alpha diversity study in patients with Clostridium difficile infection and asymptomatic carriers. 10th Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Las Palmas de Gran Canaria, 06/02/2019 – 08/02/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).

    Gut microbiota as a new predictive factor in active relapsing-remitting multiple sclerosis. 10th Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Las Palmas de Gran Canaria, 06/02/2019 - 08/02/2019 Spanish Society of Probiotics and Prebiotics (SEPyP).

    22nd Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 24/05/2018 - 26/05/2018 Spanish Society of Infectious Diseases and Clinical Microbiology.

    Estudio de la microbiota intestinal en pacientes con dermatitis atópica moderada [Study of the gut microbiota in patients with moderate atopic dermatitis]. 22nd Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 24/05/2018 - 26/05/2018. Spanish Society of Infectious Diseases and Clinical Microbiology.

    Estudio de la microbiota intestinal en pacientes con psoriasis [Study of the gut microbiota in patients with psoriasis]. 22nd Congress of the Spanish Society of Infectious Diseases and Clinical Microbiology 2018. Bilbao, 24/05/2018 - 26/05/2018. Spanish Society of Infectious Diseases and Clinical Microbiology.

    Probióticos en la dermatitis atópica: una nueva línea de tratamiento [Probiotics in atopic dermatitis: a new line of treatment]. 8th National Congress of Community Pharmacists. Alicante, 24/05/2018. Spanish Society of Family and Community Pharmacy.

    A randomized clinical trial to evaluate the safety and the effect of a probiotic mixture on PASI index in patients with moderate psoriasis. 9th Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Zaragoza, 15/02/2018 - 16/02/2018. Spanish Society of Probiotics and Prebiotics (SEPyP).

    Microbiome core in patients with Relapsing-Remitting Multiple Sclerosis. 9th Workshop of the Spanish Society of Probiotics and Prebiotics (SEPyP). Zaragoza, 15/02/2018 - 16/02/2018. Spanish Society of Probiotics and Prebiotics (SEPyP). Corresponding author.

    Efecto del tratamiento con un probiótico por vía oral en la sintomatología de la dermatitis atópica en niños y su efecto en la composición del microbioma intestinal [Effect of oral probiotic treatment on the symptomatology of atopic dermatitis in children and its effect on the composition of the gut microbiome]. AEDV 2017, 45th National Congress of Dermatology and Venereology. Madrid, 10/05/2017 - 13/05/2017. Spanish Academy of Dermatology and Venereology.

    El tratamiento oral con una mezcla de probióticos reduce el índice SCORAD y el uso de corticoides tópicos en pacientes jóvenes con dermatitis atópica [Oral treatment with a probiotic mixture reduces the SCORAD index and the use of topical corticosteroids in young patients with atopic dermatitis]. Randomised clinical trial. 8th Workshop of the Spanish Society of Probiotics and Prebiotics in Santiago 2017. Santiago de Compostela, 23/02/2017 - 24/02/2017. Spanish Society of Probiotics and Prebiotics.

    Academic awards for science outreach:

    Research Patronage Award 2019. Given by the Social Council of the University of Alicante.

    National Research Award, Pfizer Psoriasis Department, Autonomous University of Madrid 2015. Bacterial Translocation in a case series of patients with psoriasis.Award for Best Research Project from the Spanish Society of Dermatology in 2015. Bacterial Translocation in a case series of patients with psoriasis.

    Runner-up award for the best national work in clinical research involving the use of probiotics. Atopic Dermatitis. A randomised clinical trial.

    National Congress of the Spanish Society of Probiotics and Prebiotics. Spanish Society of Probiotics and Prebiotics (SEPyP) Workshop 2017

    National Award for the best orally communicated clinical research paper. Psoriasis. A randomised clinical trial. National Congress of the Spanish Society of Probiotics and Prebiotics, SEPyP Workshop 2018.

    Award for the Best Oral Communication of Clinical Uses. Multiple sclerosis and microbiota. Original Investigation. Spanish Society of Probiotics and Prebiotics, SEPyP Workshop 2019.

    National Award: Runner-up for the best work in poster format. Diferencias en la microbiota intestinal de pacientes portadores asintomáticos y sintomáticos con infección por clostridium difficile [Differences in the gut microbiota of asymptomatic and symptomatic patients with clostridium difficile infection]. Patient cohort study.

    National Congress of the Spanish Society of Microbiota, Probiotics and Prebiotics. Spanish Society of Probiotics and Prebiotics (SEPyP) Workshop, Granada, 2020